CLINICAL_TRIALS
trial_result
· 2025-03-03
Clinical Trial Update: The Norwegian Tenecteplase Stroke Trial 2 [Phase 3]
Summary
A Phase 3 trial evaluating tenecteplase for acute ischemic stroke in Norway has been terminated; no detailed results are provided.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Haukeland University Hospital | Conditions: Stroke, Acute, Cerebrovascular Disorders | Phase 3 | Status: TERMINATED